Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus

Summary by PharmaVOICE
With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater understanding of its drivers.

1 Articles

PharmaVOICEPharmaVOICE
Center

Merck & Co. assembles an Alzheimer’s comeback with a next-gen precision focus

With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater understanding of its drivers.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

PharmaVOICE broke the news in on Friday, August 1, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

Kenilworth, New Jersey icon

Kenilworth, New Jersey

News
For You
SearchBlindspotLocal